Exagen News - XGN

Company Name	Stock Ticker Symbol	Market	Type
Exagen Inc	XGN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.02	-1.43%	1.38	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
1.37	1.37	1.4098	1.38	1.40

more quote information »

Recent News

Date	Time	Source	Heading
3/18/2024	08:00	GLOBE	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
3/18/2024	07:12	IHMARKETNEWS	Anticipation Builds on Wall Street for Federal Reserve’s..
3/08/2024	09:00	GLOBE	Exagen Inc. to Participate in the KeyBanc Capital..
3/07/2024	16:05	GLOBE	Exagen to Announce Fourth Quarter 2023 and Full-Year..
3/06/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	07:12	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	16:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/08/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	15:16	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/30/2024	16:05	GLOBE	Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
1/22/2024	16:15	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/08/2024	08:00	EDGAR2	Form 8-K - Current report
1/07/2024	12:00	GLOBE	Exagen Inc. Announces Select Preliminary Full-Year 2023..
12/11/2023	16:05	EDGAR2	Form 8-K - Current report
11/30/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/29/2023	17:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/27/2023	16:05	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
11/20/2023	08:00	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/17/2023	16:30	EDGAR2	Form 8-K - Current report
11/17/2023	16:06	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/13/2023	17:24	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:05	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	GLOBE	Exagen Inc. Reports Strong Third Quarter 2023 Results
11/09/2023	16:05	GLOBE	Exagen Inc. and Johns Hopkins University Announce License..
11/02/2023	16:05	GLOBE	Exagen Inc. to Participate in the 2023 Canaccord Genuity..
10/30/2023	16:05	GLOBE	Exagen to Announce Third Quarter 2023 Financial Results on..
10/18/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/17/2023	14:50	DJN	Exagen Agrees to Pay Over $650K to Resolve Kickback..
9/28/2023	16:05	GLOBE	Exagen Announces Acceptance of Multiple Abstracts at ACR..
9/12/2023	16:05	GLOBE	Exagen Inc. to Participate in the 2023 Cantor Fitzgerald..
9/06/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/07/2023	09:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	08:00	EDGAR2	Form 8-K - Current report
8/07/2023	08:00	GLOBE	Exagen Inc. Reports Strong Second Quarter 2023 Results
7/26/2023	16:05	GLOBE	Exagen Inc. to Participate in the Canaccord Genuity 43rd..
7/25/2023	16:05	GLOBE	Exagen to Announce Second Quarter 2023 Financial Results on..
7/24/2023	16:05	EDGAR2	Form 8-K - Current report
7/24/2023	16:05	GLOBE	Exagen Inc. Appoints Paul Kim to Board of Directors
5/30/2023	09:00	GLOBE	Exagen Inc. to Participate in the William Blair 43rd Annual..
5/15/2023	16:05	GLOBE	Exagen Inc. Reports First Quarter 2023 Results
5/01/2023	16:05	GLOBE	Exagen Announces Campaign for Lupus Awareness Month